These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17976024)

  • 21. Mysterious oligomerization of the amyloidogenic proteins.
    Uversky VN
    FEBS J; 2010 Jul; 277(14):2940-53. PubMed ID: 20546306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies.
    Drzezga A
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S4-11. PubMed ID: 18197407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for the inhibition of protein aggregation in human diseases.
    Bartolini M; Andrisano V
    Chembiochem; 2010 May; 11(8):1018-35. PubMed ID: 20401887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview.
    Chandel TI; Zaman M; Khan MV; Ali M; Rabbani G; Ishtikhar M; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():1115-1129. PubMed ID: 28890370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining molecular dynamics simulations and experimental analyses in protein misfolding.
    Wille H; Dorosh L; Amidian S; Schmitt-Ulms G; Stepanova M
    Adv Protein Chem Struct Biol; 2019; 118():33-110. PubMed ID: 31928730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.
    Mathis CA; Klunk WE; Price JC; DeKosky ST
    Arch Neurol; 2005 Feb; 62(2):196-200. PubMed ID: 15710847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation.
    Herrera F; Gonçalves S; Outeiro TF
    Methods Enzymol; 2012; 506():157-74. PubMed ID: 22341224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.
    Eftekharzadeh B; Hyman BT; Wegmann S
    Mech Ageing Dev; 2016 Jun; 156():1-13. PubMed ID: 27005270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.
    Cremades N; Dobson CM
    Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-folding and aggregation of amyloid nanofibrils.
    Paparcone R; Cranford SW; Buehler MJ
    Nanoscale; 2011 Apr; 3(4):1748-55. PubMed ID: 21347488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
    Nakamura T; Gu Z; Lipton SA
    Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the understanding of protein misfolding and aggregation through molecular dynamics simulation.
    Rahman A; Saikia B; Gogoi CR; Baruah A
    Prog Biophys Mol Biol; 2022 Nov; 175():31-48. PubMed ID: 36044970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of extracellular chaperones in amyloidosis.
    Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
    J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molten globule precursor states are conformationally correlated to amyloid fibrils of human beta-2-microglobulin.
    Skora L; Becker S; Zweckstetter M
    J Am Chem Soc; 2010 Jul; 132(27):9223-5. PubMed ID: 20565073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel therapeutic strategies for the treatment of protein-misfolding diseases.
    Rochet JC
    Expert Rev Mol Med; 2007 Jun; 9(17):1-34. PubMed ID: 17597554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid peptides and proteins in review.
    Harrison RS; Sharpe PC; Singh Y; Fairlie DP
    Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.